Clinical predictors of functional outcome at three months
| Characteristic | Outcome | p Value univariate | p Value multivariate | Total (n) | |
|---|---|---|---|---|---|
| Favourable (mRS 0–2) | Poor or death (mRS 3–6) | ||||
| mRS, modified Rankin scale score; NIHSSS, National Institutes of Heath stroke scale score; VA, vertebral artery. | |||||
| No of patients | 14 (35%) | 26 (65%) | 40 | ||
| Age ⩽60 | 9 (45%) | 11 (55%) | 20 | ||
| Age >60 | 5 (25%) | 15 (75%) | NS | 20 | |
| Sex | |||||
| Male | 7 (32%) | 15 (68%) | 22 | ||
| Female | 7 (39%) | 11 (61%) | NS | 18 | |
| Diabetes | |||||
| Yes | 0 (0%) | 1 (100%) | 1 | ||
| No | 14 (37%) | 24 (63%) | NS | 38 | |
| Smoking | |||||
| Yes | 4 (31%) | 9 (69%) | 13 | ||
| No | 10 (38%) | 16 (62%) | NS | 26 | |
| Hypercholesterolaemia | |||||
| Yes | 4 (31%) | 9 (69%) | 13 | ||
| No | 10 (38%) | 16 (62%) | NS | 26 | |
| Hypertension | |||||
| Yes | 5 (26%) | 14 (74%) | 19 | ||
| No | 9 (45%) | 11 (55%) | NS | 20 | |
| NIHSSS on admission | |||||
| ⩽220 | 13 (59%) | 9 (41%) | 22 | ||
| >20 | 1 (6%) | 17 (94%) | <0.0001 | 0.002 | 18 |
| Coma | |||||
| Yes | 1 (7%) | 14 (93%) | 15 | ||
| No | 13 (52%) | 12 (48%) | 0.004 | NS | 25 |
| Quadriplegia | |||||
| Yes | 1 (6%) | 15 (94%) | 16 | ||
| No | 13 (54%) | 11 (46%) | 0.002 | NS | 24 |
| Time to treatment | |||||
| ⩽6 hours | 12 (41%) | 17 (59%) | 29 | ||
| >6 hours | 2 (18%) | 9 (82%) | NS | NS | 11 |
| Stroke aetiology | |||||
| Cardioembolic | 6 (50%) | 6 (50%) | 12 | ||
| Unknown | 2 (20%) | 8 (80%) | NS | NS | 10 |
| Large artery disease | 4 (29%) | 10 (71%) | 14 | ||
| VA dissection | 2 (50%) | 2 (50%) | 4 | ||